Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer.

标题
Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 40, Issue 16_suppl, Pages 3100-3100
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-06-07
DOI
10.1200/jco.2022.40.16_suppl.3100

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More